ArticleAnnals of internal medicine2010

ACP Journal Club. In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone.

Amy T Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.